{"id":"W3200209831","doi":"10.1007/s12325-021-01878-5","title":"Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial","year":2021,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Propeller Health; Pearl Therapeutics; Allergan; Forest Laboratories; Esperion Therapeutics; AstraZeneca; Galderma; Novo Nordisk; Eisai; Brigham and Women's Hospital; Kiniksa Pharmaceuticals; Sunovion; Pfizer","keywords":"Medicine; COPD; Placebo; Internal medicine; Formoterol; Exacerbation; Maintenance therapy; Randomized controlled trial; Mace; Asthma; Conventional PCI; Myocardial infarction; Chemotherapy; Budesonide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001421678,0.0002814117,0.001966187,0.0007806291,0.00004056809,0.00001306317,0.0002942525,0.00009880125,0.0009468029],"category_scores_gemma":[0.001363897,0.0002289598,0.0008846834,0.002632018,0.0002295151,0.0002033754,0.00008381419,0.0002530644,0.000005639251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001613162,"about_ca_system_score_gemma":0.0004504497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008013411,"about_ca_topic_score_gemma":0.00004372286,"domain_scores_codex":[0.9963797,0.0007741912,0.001057898,0.0006023536,0.0007555868,0.0004302753],"domain_scores_gemma":[0.9961015,0.001989829,0.0003082656,0.0008248295,0.0005754969,0.0002001045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.770344,0.001188747,0.004073653,0.00007769234,0.001525282,0.00004995469,0.0003156328,0.0005959033,0.0286128,0.00008844167,0.00001249484,0.1931154],"study_design_scores_gemma":[0.9421406,0.000919575,0.01023791,0.0002122024,0.0005009802,0.00000416529,0.0006938545,0.001332916,0.03974003,0.0002274224,0.003701167,0.0002892273],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9490483,0.04644417,0.0005521122,0.0009298131,0.0002988235,0.002077763,0.00007370205,0.00002788855,0.000547377],"genre_scores_gemma":[0.9586626,0.03827354,0.001651475,0.000700322,0.000226215,0.0001373258,0.0001649066,0.00004617672,0.0001374703],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1928262,"threshold_uncertainty_score":0.9999664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02147761966077214,"score_gpt":0.3626173923779226,"score_spread":0.3411397727171505,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}